missing translation for 'onlineSavingsMsg'
Learn More
Learn More
ACROBiosystems PD-1, Biotinylated, PD-L1 Inhibitor Screening ELISA Assay Pair
Description
Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.
Specifications
Specifications
| Product Type | Inhibitory Kit |
| Kit Contents | This inhibitor screening ELISA pair is designed to facilitate the identification and characterization of new PD-1 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human PD-1 to immobilized human PD-L1 in a fu |
| Quantity | 96 Tests |
| Shipping Condition | RT |
| Storage Requirements | -20°C, aviod light |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?